Ago Tumor ???c s? d?ng b?ng u?ng. U?ng v?i one c?c n??c và s? d?ng ??u ??n m?i ngày.mutations in addition (LoE 2b/B/Back+/?). Despite the fact that EMA approval has long been determined by research of germline mutation carriers only, in picked situations perseverance of BRCA standing from tumor tissue can be done to evaluate the prospective sensi